EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Development of Human Recombinant Antibodies Against ROR1 Tumor Antigen

Peyman Bemani, Setareh Moazen, Elham Nadimi, Foroogh Nejatollahi

Reports of Biochemistry and Molecular Biology · 2022

DOI: 10.61186/rbmb.11.2.282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reports of Biochemistry and Molecular Biology, 2022. Verfasst von Peyman Bemani und 3 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bemani, P., Moazen, S., Nadimi, E., & Nejatollahi, F. (2022). Development of Human Recombinant Antibodies Against ROR1 Tumor Antigen. Reports of Biochemistry and Molecular Biology. https://doi.org/10.61186/rbmb.11.2.282

Vancouver

Bemani P, Moazen S, Nadimi E, Nejatollahi F. Development of Human Recombinant Antibodies Against ROR1 Tumor Antigen. Reports of Biochemistry and Molecular Biology. 2022. doi:10.61186/rbmb.11.2.282

BibTeX
@article{Bemani2022,
  author = {Bemani, Peyman and Moazen, Setareh and Nadimi, Elham and Nejatollahi, Foroogh},
  title = {Development of Human Recombinant Antibodies Against ROR1 Tumor Antigen},
  journal = {Reports of Biochemistry and Molecular Biology},
  year = {2022},
  doi = {10.61186/rbmb.11.2.282}
}
Kostenlos starten →